Delay of renal progression in methylmalonic acidemia using angiotensin II inhibition: a case report

Area of Science:

• Biochemistry
• Nephrology
• Genetics

Background:

• Methylmalonic acidemia (MMA) is a metabolic disorder affecting propionate metabolism.
• Current management focuses on low-protein diets to control methylmalonic acid levels.
• Renal complications, particularly tubulointerstitial nephritis, are increasingly observed in long-term MMA patient follow-up.

Observation:

• A case study of a girl with MMA and chronic renal insufficiency is presented.
• The patient developed tubulointerstitial nephritis as a complication of MMA.
• Angiotensin II inhibition appeared to delay the progression of renal dysfunction.

Findings:

• Tubulointerstitial nephritis is a significant renal complication in methylmalonic acidemia.
• The effectiveness of angiotensin II inhibition in managing renal complications in MMA warrants further investigation.
• This case highlights the importance of long-term renal monitoring in patients with inborn errors of metabolism.

Implications:

• Early recognition and management of renal dysfunction are crucial for MMA patients.
• Angiotensin II inhibition may offer a therapeutic strategy to mitigate renal damage in MMA.
• Further research is needed to elucidate the mechanisms and optimize treatment for renal complications in metabolic disorders.